Unraveling the mechanisms involved in motor neuron degeneration in ALS

Annual Review of Neuroscience
Lucie I BruijnDon W Cleveland

Abstract

Although Charcot described amyotrophic lateral sclerosis (ALS) more than 130 years ago, the mechanism underlying the characteristic selective degeneration and death of motor neurons in this common adult motor neuron disease has remained a mystery. There is no effective remedy for this progressive, fatal disorder. Modern genetics has now identified mutations in one gene [Cu/Zn superoxide dismutase (SOD1)] as a primary cause and implicated others [encoding neurofilaments, cytoplasmic dynein and its processivity factor dynactin, and vascular endothelial growth factor (VEGF)] as contributors to, or causes of, motor neuron diseases. These insights have enabled development of model systems to test hypotheses of disease mechanism and potential therapies. Along with errors in the handling of synaptic glutamate and the potential excitotoxic response this provokes, these model systems highlight the involvement of nonneuronal cells in disease progression and provide new therapeutic strategies.

References

Sep 1, 1992·Journal of Neuropathology and Experimental Neurology·M Corbo, A P Hays
Aug 1, 1991·Annals of Neurology·J D RothsteinD B Drachman
Jan 1, 1992·Experimental Neurology·A Alvarez-Buylla
Jul 1, 1990·Annals of Neurology·J D RothsteinJ T Coyle
Jul 1, 1971·Journal of Neuropathology and Experimental Neurology·S M Chou, A V Fakadej
Sep 1, 1968·Neurology·S Carpenter
Feb 1, 1984·Journal of the Neurological Sciences·M B Delisle, S Carpenter
Sep 1, 1984·Journal of Neuropathology and Experimental Neurology·A HiranoG Saccomanno
Nov 1, 1981·Journal of Neuropathology and Experimental Neurology·Y KawamuraH Doi
Jun 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·P J ShawH J Wastell
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
May 1, 1995·Journal of Neurochemistry·A C BowlingR H Brown
Dec 22, 1994·The New England Journal of Medicine·M E Gurney
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RippsJ W Gordon
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·D R BorcheltD W Cleveland
Aug 1, 1993·Neuropathology and Applied Neurobiology·P InceK G Baimbridge
Aug 12, 1993·Nature·J S BeckmanW H Koppenol
Jan 1, 1996·Annual Review of Neuroscience·M K Lee, D W Cleveland
Aug 1, 1996·Trends in Neurosciences·G W Kreutzberg
Oct 1, 1996·Neurology·J L Elliott, W D Snider
Oct 1, 1996·Neuropathology and Applied Neurobiology·L I Bruijn, D W Cleveland
Sep 20, 1997·The Journal of Biological Chemistry·V C CulottaJ D Gitlin
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·C JacobB L Vallee
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·L B CorsonD W Cleveland
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·R D Palmiter

❮ Previous
Next ❯

Citations

Jun 15, 2007·Acta Neuropathologica·Dennis W DicksonCatalina Amador-Ortiz
May 24, 2011·Journal of Neurology·Massimiliano FilostoAlessandro Padovani
Nov 16, 2007·Pflügers Archiv : European journal of physiology·Nael Nadif Kasri, Linda Van Aelst
Mar 30, 2013·Molecular Genetics and Genomics : MGG·Jakob Maximilian MoserThomas Schmitt-John
Dec 25, 2008·Dysphagia·Teresa E LeverAlexander K Murashov
May 5, 2012·Journal of Neural Transmission·Joanna TarasiukPiotr Lewczuk
Mar 10, 2010·Apoptosis : an International Journal on Programmed Cell Death·Yan Wang, Zheng-Hong Qin
Jun 10, 2006·Journal of Inherited Metabolic Disease·N Gregersen
Mar 22, 2013·Journal of Fluorescence·Meng-Meng LiBao-Xiang Zhao
Feb 21, 2008·Neuromolecular Medicine·Mary E McCrate, Brian K Kaspar
Jul 25, 2008·Journal of Molecular Neuroscience : MN·Daniel OffenGerhard Ransmayr
Nov 9, 2010·Journal of Molecular Neuroscience : MN·Michal Dadon-NachumDaniel Offen
Oct 24, 2007·Molecular Neurobiology·Jayanth ChandranHuaibin Cai
Feb 3, 2009·Molecular Neurobiology·Kohsuke KanekuraMasaaki Matsuoka
Aug 7, 2012·Cell Stress & Chaperones·Ari M ChowIan R Brown
Nov 19, 2009·Neurotoxicity Research·Yiquan ChenGilles J Guillemin
Apr 17, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Pavitra S RamachandranBeverly L Davidson
Oct 1, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Marcelo R Vargas, Jeffrey A Johnson
Dec 11, 2013·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Duraisamy Udhayakumari, Sivan Velmathi
Jul 9, 2013·Experimental Cell Research·Jonathan DeGeer, Nathalie Lamarche-Vane
Jun 6, 2009·Expert Reviews in Molecular Medicine·Marcelo R Vargas, Jeffrey A Johnson
Feb 21, 2009·Biochemistry·Duane D WinklerP John Hart
Jan 5, 2006·Journal of the American Chemical Society·Li ZengChristopher J Chang
Mar 9, 2013·Cell Death & Disease·J GuoW Han
Apr 5, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·James C DodgeBrian K Kaspar
Apr 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Chris TownePatrick Aebischer
Sep 23, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·James C DodgeBrian K Kaspar
Nov 26, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Chris TownePatrick Aebischer
May 9, 2007·Nature Medicine·Rishi RakhitAvijit Chakrabartty
Oct 22, 2008·Nature Neuroscience·Angelo C LeporeNicholas J Maragakis

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
of
protein folding
coimmunoprecipitation
electron microscopy
antisense oligonucleotide
glycosylation

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis